NEW YORK (GenomeWeb News) – French high-content screening vendor Fluofarma said recently that it has entered into a multi-year assay development agreement with Roche.

Under the terms of the partnership, Roche and Fluofarma will work together to develop miniaturized cell-based assays using high-throughput flow cytometry and computational models to improve the predictability of hepatotoxicity and safety profiling of compounds in liver cells.

Financial terms of the partnership were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.